Literature DB >> 34850168

Treat the VTE and worry less about the hemorrhage: A sigh of relief or is the jury still out for therapeutic anticoagulation in high-grade glioma?

Jennie W Taylor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34850168      PMCID： PMC8917400          DOI： 10.1093/neuonc/noab277

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  7 in total

1.  Intracerebral haemorrhage in patients with brain metastases receiving therapeutic anticoagulation.

Authors:  Peter Wood; Giovanni Boyer; Elie Mehanna; Daniel Cagney; Nayan Lamba; Paul Catalano; Jean M Connors; Liangge Hsu; Mallika Mendu; Shyam Tanguturi; Brian Alexander; Daphne Haas-Kogan; Ayal Aizer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-03-09       Impact factor: 10.154

2.  Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin.

Authors:  Charlene Mantia; Erik J Uhlmann; Maneka Puligandla; Griffin M Weber; Donna Neuberg; Jeffrey I Zwicker
Journal:  Blood       Date:  2017-05-03       Impact factor: 22.113

3.  Thromboembolic disease in patients with high-grade glioma.

Authors:  James R Perry
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

4.  Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?

Authors:  Jasmin Jo; Joseph Donahue; Guneet Sarai; Gina Petroni; David Schiff
Journal:  Neuro Oncol       Date:  2022-03-12       Impact factor: 13.029

Review 5.  Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis.

Authors:  Angelo Porfidia; Marzia Giordano; Carmelo L Sturiale; Sonia D'Arrigo; Marco P Donadini; Alessandro Olivi; Walter Ageno; Roberto Pola
Journal:  Brain Behav       Date:  2020-04-21       Impact factor: 2.708

6.  Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype.

Authors:  Maria Diaz; Jasmin Jo; Mark Smolkin; Sarah Jane Ratcliffe; David Schiff
Journal:  Neurology       Date:  2020-12-22       Impact factor: 9.910

7.  SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors.

Authors:  Tobias Walbert; Rebecca A Harrison; David Schiff; Edward K Avila; Merry Chen; Padmaja Kandula; Jong Woo Lee; Emilie Le Rhun; Glen H J Stevens; Michael A Vogelbaum; Wolfgang Wick; Michael Weller; Patrick Y Wen; Elizabeth R Gerstner
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.